SAMUEL R MD NUSSBAUM
CIK 1199310 · EVP & Chief Medical Officer · last filed 2021-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$521.6K
Companies
6
Total Filings
45
Lifetime Open-Market Net
-$54.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (PROG) Delisted | Director | 47,518 | $0.88 | $42.0K | $0 | 1 | 2021-06-16 |
| Motus GI Holdings, Inc. (MOTS) Delisted | Director | 258 | $0.00 | $0 | $50.0K | 7 | 2021-02-19 |
| CHRS | Director | — | $1.44 | — | $0 | 4 | 2021-01-13 |
| ANTX | EVP & Chief Medical Officer | 110,972 | $4.70 | $521.6K | -$1.65M | 1 | 2015-05-21 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Medical Officer | 110,972 | $482.58 | $53.55M | -$9.24M | 3 | 2015-05-13 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Medical Officer | 143,757 | — | — | -$43.73M | 29 | 2014-11-04 |
Recent Filings · Page 2 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-11 | CHRS | Grant (A) | — | $0 | EDGAR |
| 2018-02-21 | Motus GI Holdings, Inc. (MOTS) Delisted | Buy (P) | +10,000 | $50.0K | EDGAR |
| 2015-05-21 | ANTX | Mixed | — | -$884.1K | EDGAR |
| 2015-05-13 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$834.1K | EDGAR |
| 2015-04-15 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$3.98M | EDGAR |
| 2015-03-04 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +7,215 | -$1.12M | EDGAR |
| 2014-11-04 | Elevance Health, Inc. (WLP) Delisted | Mixed | — | -$2.47M | EDGAR |
| 2014-09-15 | Elevance Health, Inc. (WLP) Delisted | Mixed | — | -$1.13M | EDGAR |
| 2014-09-09 | Elevance Health, Inc. (WLP) Delisted | Mixed | — | -$2.01M | EDGAR |
| 2014-08-29 | Elevance Health, Inc. (WLP) Delisted | Mixed | — | -$1.81M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.